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Exercise and Vagal Reflex
in Long QT Syndrome Type 1*
Koonlawee Nademanee, MD
Los Angeles, California
“I have never taken any exercise except sleeping and resting.”
Mark Twain (1)
Mark Twain’s view on exercise would serve very well for
many patients with long QT syndrome type 1 (LQT1)—the
most common form of the long QT syndrome (LQTS).
LQT1 is caused by loss-of-function mutations in KCNQ1,
which encode the adrenergic-sensitive IKs channel (2).
QT1 patients usually develop life-threatening arrhythmias
uring increased sympathetic activity situations (i.e., phys-
cal exercise, emotional or physical stress, especially swim-
ing). Recent studies have shed some light on adverse
ffects of exercise and increased adrenergic activity on
QT1 patients.
See page 2515
The IKs channel is part of a macromolecular channel
complex consisting of -subunits encoded by KCNQ1
Kv7.1), KCNE1 -subunits, and the regulatory A-kinase
anchoring protein Yotiao, which binds to the KCNQ1
C-terminus. During -stimulation, when cyclic adenosine
monophosphate (cAMP) levels rise, the key enzymes (pro-
tein kinase A and protein phosphatase-1) that are localized
to the channel complex by Yotiao, control phosphorylation
of KCNQ1 at N-terminal position S27, and in turn control
IKs enhancement during adrenergic stimulation (4). Muta-
tions in either KCNQ1 or KCNE1 can alter this regulation
and create disorder in the cellular response to -adrenergic
timulation (2,4). LQT1 patients who have mutations
ocated in the transmembrane region of the channel develop
greater prolongation in the QTc during exercise and face
higher risk for cardiac events (5). Recent studies reveal that
issense mutations of KCNQ1 in the intracellular cytoplasmic
oops (C-loops) within the transmembrane domain S2-S3 and
4-S5, especially compared to other types of mutations, are
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rrhythmias (5). Interestingly, -blockers are much more
effective in reducing arrhythmic events and sudden cardiac
death in the carriers of C-loop KCNQ1 mutations, com-
pared with the those of other mutations in LQT1 patients
(6). In addition, functional studies of the C-loop mutations
show not only a decrease in IKs but also a marked reduction
in channel activation in response to -adrenergic stimula-
ion. This partially explains why LQT1 patients with this
utation, during exercise or during increased adrenergic
ctivity, have a paradoxically increased QT interval and a
reater risk for life-threatening events independently of clinical
ariables. The mutation A341V in KCNQ1 (S6 transmem-
rane segment)—found in a large South African founder
opulation—is associated with an unusually severe clinical
henotype compared with other LQT1 mutations (7). This
utation also causes an impairment of -adrenergic stimula-
ion largely due to alteration of cAMP-dependent up-
egulation of IKs (4). Since the mutation is located at the end
f the S6 domain that probably interacts with the S4-S5
-loop, it can be assumed that other KCNQ1 mutations,
ausing impairment similar to that of the C-loop mutations,
ill likely have the same clinical picture with respect to the
ncreased cardiac risk and response to -blocker.
The previous findings clearly demonstrate the impact of
the location, coding type, and topology of the channel
mutation on the clinical manifestation and outcomes of
LQT1 patients. From this, it is reasonable to consider
genetic testing for all LQTS patients for diagnosis and
genotyping, risk stratification, and potential response to
-blocker. However, genetic studies are relatively expensive
and not widely available in many parts of the world.
Fortunately, exercise testing in LQTS may provide valuable
information similar to that obtained from the genetic
testing. A simple stress test is particularly helpful in un-
masking concealed form of LQTS, especially LQT1 and
LQT2. Because of the loss of functional IKs channel,
LQT1 patients are unable to enhance the channel function
during the faster rate resulting in paradoxical QTc prolon-
gation during peak exercise and early recovery phase of
exercise (1 min after exercise) (8). It was found that QTc
prolongation during early recovery is the best single param-
eter to predict LQT1 genotype. In contrast, LQT2 and
LQT3 patients have a relatively normal QT adaptation
during peak exercise and during the early recovery phase of
exercise, but LQT2 patients are more likely to have QT
prolongation at a late phase of exercise recovery (8). The
previous findings strongly support exercise stress test for
unmasking concealed LQTS patients and probably in iden-
tifying carriers of LQT1 and LQT2 mutation. The next
question is: Could exercise be used for risk stratification as
well?
In this issue of the Journal, Crotti et al. (10) provide a
preliminary answer to this question. They studied 169
LQTS genotype-positive patients below the age of 50 years,
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A341V LQT1 patients and 122 Italian LQTS patients (66
LQT1, 50 LQT2, and 6 LQT3). Using a bicycle ergometer,
the investigators found that symptomatic LQT1 patients
from both populations had a greater heart rate reduction
(17%) at the first minute of recovery phase from the peak
heart rate during exercise when compared with the asymp-
tomatic LQT1 patients. In contrast, there was no difference
in heart rate reduction immediately after exercise between
the symptomatic and asymptomatic LQT2 and LQT3
patients. Crotti et al. concluded that heart rate reduction
immediately after exercise—a marker of vagal reflex re-
sponse similar to the phenylephrine baroreflex sensitivity
test—can be used for risk stratification in LQT1 patients.
They also stated that potent vagal reflexes, as detected by
exaggerated heart rate reduction during the first minute
post-exercise, are associated with high risk for arrhythmic
events in LQT1 patients. This observation, if confirmed by
more prospective studies, would certainly have an impact of
how one evaluates LQTS patient.
While the study by Crotti et al. (10) is a welcome
addition to the rapidly evolving field of ion channelopathies,
one has to exercise caution in interpreting their data. First,
it is a retrospective study in a highly selective LQTS popula-
tion; the South African LQT1 patients with KCNQ1
(A341V) included in this study are a unique highly symptom-
atic group and already are known to have powerful vagal reflex
from their previous study (11). Even though the investigators
add their Italian LQTS patients into the mix, one has to be
wary of the selection bias that may skew the results. In fact,
more than half of the Italian LQT1 patients in this study
had mutations in the membrane spanning region or in the
C-loop. Combined with the South African population that
has the malignant form of KCNQ1 (A341V), the majority
of the LQT1 population in this study are a high-risk
genotype-phenotype population. This with a relatively small
sample size makes it difficult to draw firm conclusion. It is
unclear how robustly the exercise stress test could determine
high-risk patients in the population of asymptomatic
LQTS. Last, it should be emphasized that the findings from
the bicycle ergometer protocol used in Crotti et al.’s study
might not be applicable to those from exercise treadmill test.
Based on their data, Crotti et al. (10) recommend exercise
stress test to all LQTS patients, especially LQT1 carriers.
However, one has to recognize that the current guideline
recommends that all LQT1 patients should be treated with
-blockers, so how is the information from exercise testgoing to alter one’s treatment plan for LQT1 patient? One
has to ask what would be done if an asymptomatic LQT1
patient had a very small reduction of heart rate 1 min
following exercise: Do we omit -blocker treatment for this
atient? More prospective studies to learn more about vagal
eflexes following exercise so that a clear-cut protocol, key
arameters, and treatment plan can be developed as a
uideline to general practitioners who care for LQT1
atients. For now, at least Crotti et al.’s findings can be used
o advise LQT1 patients to follow Mark Twain’s exercise
rotocol.
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